Trials / Unknown
UnknownNCT04821570
To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment
Cancer Therapy and Immunogenicity of COVID Vaccine (CANINE Trial)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- University of Kansas Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This is a trial of prospective collection of serial blood samples after administration of COVID-19 vaccine in patients with cancer who are receiving active cancer treatment, planned to start therapy with 14 days of consent, or have had stem cell transplant. Cancer treatments and administration of vaccine are not controlled by the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | COVID-19 Vaccine | Per recommended dosing schedule |
Timeline
- Start date
- 2021-02-23
- Primary completion
- 2024-03-28
- Completion
- 2025-03-28
- First posted
- 2021-03-29
- Last updated
- 2023-04-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04821570. Inclusion in this directory is not an endorsement.